Home > Healthcare > Pharmaceuticals > Finished Drug Form > Facial Injectables Market

Facial Injectables Market Share

Report ID: GMI3909
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Facial Injectables Market Share

The facial injectables sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Facial Injectables Market Companies

Some of the eminent market participants operating in the facial injectables industry include:

AbbVie Inc.
Anika Therapeutics, Inc.
APAX Partners
Bioplus Co., Ltd.
Croma-Pharma GmbH
Galderma SA
Ipsen Pharma
Lutronic Corporation
Medytox
Merz Pharma
Prollenium Medical Technologies
Revance Therapeutics, Inc.
Sinclair
Suneva Medical
Teoxane

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of facial injectables reached USD 9.4 billion in 2023 and is set to witness 10.3% CAGR from 2024 to 2032, owing to the increasing demand for minimally invasive cosmetic procedures, and advancements in injectable technology.

The botulinum toxin product segment in the facial injectables industry is projected to record USD 8.2 billion by 2032, due to its widespread use in reducing wrinkles and fine lines.

The wrinkle reduction application segment in the facial injectables market recorded USD 2.6 billion in 2023 and is projected grow at significant rate from 2024 to 2032, on account of the increasing disposable income levels and broader accessibility to cosmetic procedures.

U.S. market is estimated to record USD 8.2 billion by 2032, led by the growing aging population that is seeking ways to maintain a youthful appearance.